Crossmark

ASO Visual Abstract: Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Non-gynecologic Cancers

Crossref DOI link: https://doi.org/10.1245/s10434-023-14867-5

Published Online: 2024-01-13

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Radomski, Shannon N.

Dunworth, Matthew

West, Junior J.

Greer, Jonathan B.

Johnston, Fabian M.

Ewald, Andrew J.
License Information

Text and Data Mining valid from 2024-01-13

Version of Record valid from 2024-01-13
More Information

Article History

First Online: 13 January 2024

Disclosures

: The authors received support from the NIH/NCI 5T32CA126607 (SNR), NIH/NCI T32CA153952 (MD), NIH/NCI U54CA268083 (AJE), American College of Surgeons Resident Research Scholarship (SNR), the Commonwealth Foundation for Cancer Research (FMJ, AJE), the Johns Hopkins SPORE in Gastrointestinal Cancer at the Sidney Kimmel Comprehensive Cancer Center (SNR, AJE), the Giovanis Institute for Translational Cell Biology (AJE), and the Black in Cancer/Emerald Foundation Postdoctoral Fellowship (JJW). AJE has unlicensed patents related to keratin 14 as a prognostic marker and to antibody strategies for anticancer therapeutics. AJE is a consultant for BioNTech. AJE’s spouse is an employee of ImmunoCore.

Document is current

Any future updates will be listed below